index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

AChR antibodies CXCL13-CXCR5 Complete Freund's adjuvant Quality of life Thymus Thymic epithelial cells Centres germinatifs ectopiques Chemokines Il-23 Genetics Glucocorticoids Chronicity Early-onset myasthenia gravis Max Human myoblasts PBMC Immunity Acetylcholine receptor antibodies MYB Auto-immunité Immune response Lamin A/C nuclei Inflammation Interferon-β M3243AG BAFF Acetylcholine receptor B cells Genetic associations Acetylcholine receptors Myasthenia Gravis MG Experimental mouse models Interferon IFN Animal models Interferon type-I CCL21 Experimental autoimmune myasthenia gravis EAMG Cardiomyopathy Inflammatory cytokines LMNA CTCF Interferon Immunology and Microbiology Section Heart failure Chemokine Long-term follow-up Myasthenia gravis Innate immunity DICER Chronic inflammation Interferonopathy Gender Cytokines Immunotherapy Interferon type I Interleukine-23 Autoimmunity MG patients MiR-125 Conduction disease Disease susceptibility Transcriptome Germinal centers Adaptive immunity Interféron de type I Exercise Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype MiR-7 Autoimmune diseases Macrophages Interferon de type I Interleukin 23 Antimir-150 Neuromuscular junction Mass cytometry CyTOF Endogenous nucleic acids Myasthénie grave COX2 Cellules th17 Th17 cells FMR1 Immune regulation Ectopic germinal centers Ferrites Fragile X syndromes Anticorps monoclonal Germinal center Acides nucléiques endogènes Maladie auto-immune Autoimmune disease Etiology Thymoma Myoblasts Experimental models COVID-19 Experimental autoimmune myasthenia gravis CD31 Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Clinical cell transplantation Gd T cells